Meet the Team

Dr. Joceyln Ng

Co-Founder, Chief Executive Officer

Dr. Jocelyn Ng is a medical doctor specialized in Healthcare Management and a clinician-innovator dedicated to bridging the gap between frontier technology and clinical practice. As CEO of Pilot Medical Group, she leads the mission to modernize private healthcare by facilitating the integration of AI, HealthTech, MedTech, and BioTech into real-world settings through evidence-based innovation.

Supporting Healthcare Organizations & Private Clinics

Dr. Ng serves as a strategic partner to healthcare providers navigating digital transformation. Under her leadership, Pilot Medical Group supports organizations in adopting novel AI technologies to enhance clinical services quality and operational efficiency, differentiating their brands in a competitive market, ensuring technologies are integrated thoughtfully to augment human care and improve customers' experience.

Empowering Innovation Partners & Startups

For founders and technology innovators, Dr. Ng provides a proven roadmap from ideation to market. She provides strategic guidance for startups through product-market fit, clinical validation and regulatory governance, helping technology partners bridge the gap between initial innovation and sustainable commercial success across the Asia-Pacific region.

Through Pilot Medical Group, Dr. Ng is committed to a future where technology and clinical integrity coexist to enhance healthcare delivery for providers and patients alike.

Dr. Jason Lau

Co-Founder, Chief Medical Officer

Drawing on years of international and local clinical experience, including surgical rotations at Harvard Medical School and Singapore General Hospital, Dr. Lau brings a highly technical and precise approach to longevity and aesthetic medicine. He combines a deep interest in regenerative science and anti-aging medicine with minimally invasive aesthetic procedures to achieve subtle, life-enhancing results that bolster his patients' self-esteem. As a published author and physician trainer, Dr. Lau remains at the forefront of medical innovation, striving to help his patients not only reach peak health but also reduce the visible effects of aging to bring out their natural beauty from within.

As Chief Medical Officer of Pilot Medical Group, Dr. Lau spearheads the clinical direction of our innovative ecosystem. He plays a pivotal role in managing our clinical incubation sandbox, where he oversees the integration of advanced AI-driven screenings and regenerative protocols into real-world practice. By bridging the gap between clinical innovation and market adoption, Dr. Lau ensures that the technologies we pilot are not only medically sound but provide high-trust, data-rich outcomes for our patients and partners alike. His leadership is dedicated to redefining proactive health management, turning Singapore into a regional gateway for the future of longevity medicine.

"My mission is to harmonize the latest advancements in anti-aging and regenerative science to ensure my patients look and feel their best, radiating confidence from the inside out."

A/Prof Cheung Wang Chi

Technology Advisor

Associate Professor Cheung Wang Chi joins us as a Technology Advisor, bringing a world-class academic foundation and deep technical expertise to our innovation ecosystem. He holds a Ph.D. from the Massachusetts Institute of Technology (MIT) and a B.A. in Mathematics from the University of Cambridge. Currently serving in the Department of Industrial Systems Engineering and Management at the National University of Singapore (NUS), A/Prof Cheung stands at the forefront of research in artificial intelligence and operations research.

His work specializes in data-driven optimization, reinforcement learning, and predictive analytics—critical areas for startups building scalable, intelligent systems. By combining the rigorous mathematical training of Cambridge with the innovation-driven ethos of MIT, A/Prof Cheung offers our partner companies high-level guidance on technical architecture and algorithmic strategy. He plays a key role in helping ventures translate complex theoretical models, such as multi-armed bandits and real-time resource allocation, into commercially viable products that drive efficiency and growth.

Prof Sam Yam

Strategic Commercial Advisor

Professor Sam Yam joins us as a Strategic Commercial Advisor, bringing world-class expertise in leadership and organizational dynamics to our venture building ecosystem. He currently serves as the Jardine Cycle & Carriage Professor and Head of the Department of Management and Organization at the National University of Singapore (NUS) Business School. Widely recognized as one of the most influential young business minds globally, he was named one of the "Best 40 Under 40 Business Professors" by Poets&Quants—the youngest academic to receive this honor at the time.

Professor Yam’s research stands at the forefront of the Future of Work, exploring the critical intersection of business ethics, leadership, and artificial intelligence. In his advisory role, he provides high-level guidance on organizational scaling, talent strategy, and the ethical implementation of technology. His insights are particularly vital for our portfolio companies as they navigate the human challenges of adopting AI, ensuring that our innovations are not only commercially successful but also organizationally sustainable.

Mr. Chung Ting Fai

Legal Advisor

Mr. Chung Ting Fai joins us as Legal Advisor, bringing over three decades of distinguished expertise in legal advocacy, regulatory strategy, and cross-border structuring to Pilot Medical Group’s governance framework.

As the Founder and Managing Partner of Chung Ting Fai & Co., he is widely respected within Singapore’s legal community. He is also well-regarded by members of the legal profession in China for his cross-border advisory work and long-standing engagement with regional institutions.

Mr. Chung advises prominent families and family offices from China, Japan, ASEAN, and Africa on complex business structuring, investment migration, trusts, legacy preservation, and estate planning. His depth of experience navigating multi-jurisdictional regulatory environments and safeguarding long-term institutional interests provides valuable perspective as Pilot Medical Group expands across Asia.

A frequent speaker and lecturer on the evolving regulatory implications of artificial intelligence, Mr. Chung offers strategic guidance on aligning technological innovation with robust governance and compliance frameworks. His counsel is particularly vital as we advance healthcare AI solutions within increasingly sophisticated data and regulatory landscapes.

Internationally, he serves as a panel arbitrator with the Hainan International Arbitration Court and as a Board Member of the Cambodia Centre for Mediation.

As Pilot Medical Group continues to scale, Mr. Chung provides the critical guidance on regulatory compliance, cross-border governance, and institutional risk management required to maintain our strong legal and ethical foundations.